US stock · Healthcare sector · Diagnostics & Research
Company Logo

Danaher Corporation

DHRNYSE

258.29

USD
-3.86
(-1.47%)
Market Closed
31.22P/E
24Forward P/E
1.56P/E to S&P500
187.892BMarket CAP
0.35%Div Yield
Upcoming Earnings
20 Oct
Shares Short
Short % of Float
- -
Short % of Shares Outs.
- -
% Held by Insiders
- -
% Held by Institutions
- -
Beta
0.89
PEG Ratio
- -
52w. high/low
331.69/233.71
Avg. Daily Volume
2.14M
Return %
Stock
S&P 500
1 year
(14.80)
(16.20)
3 years
82.70
22.35
5 years
206.79
44.82
Scale: |
High
Low
33.82
26.20
33.43
17.89
29.02
18.09
36.08
26.46
42.52
29.83
43.33
36.01
58.67
42.59
66.33
53.16
74.01
61.60
82.64
61.60
95.16
78.22
110.86
91.84
154.00
96.44
248.32
119.60
333.96
211.22
328.57
233.71
Currency: USD
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
TTM
Revenue per share
15.58
17.71
19.88
17.43
20.21
23.80
26.33
27.47
28.36
29.46
24.42
26.34
28.39
25.05
31.55
41.22
43.07
Earnings per share
1.82
2.20
2.06
1.80
2.74
3.21
3.45
3.87
3.70
4.81
3.69
3.58
3.78
4.21
5.16
9.00
8.67
FCF per share
2.29
2.38
2.61
2.51
2.86
3.39
4.26
4.36
4.50
4.54
4.24
4.11
4.80
4.64
7.67
9.89
9.85
Dividends per share
0.04
0.06
0.06
0.07
0.08
0.09
0.12
0.07
0.32
0.51
1.28
0.54
0.62
1.05
0.87
1.04
1.11
CAPEX per share
0.22
0.26
0.30
0.29
0.33
0.49
0.66
0.79
0.85
0.91
0.85
0.89
0.94
0.89
1.12
1.81
1.79
Book Value per sh.
10.79
14.60
15.36
18.13
20.99
25.00
27.43
32.16
33.29
33.94
33.28
37.88
40.27
42.34
56.31
63.21
- -
Comm.Shares outs.
616
622
639
642
653
676
693
696
702
698
691
696
701
715
706
715
715
Avg. annual P/E ratio
13.5
13.2
13.2
13.0
11.0
11.6
11.6
12.8
15.8
13.8
20.2
24.0
26.8
31.7
35.7
30.3
31.2
P/E to S&P500
0.7
0.8
0.6
0.2
0.5
0.7
0.8
0.8
0.9
0.7
0.9
1.0
1.1
1.3
0.9
1.0
1.6
Avg. annual div. yield
0.2%
0.2%
0.2%
0.3%
0.3%
0.2%
0.3%
0.2%
0.6%
0.8%
1.7%
0.6%
0.6%
0.8%
0.5%
0.4%
0.4%
Revenue (m)
9,596
11,026
12,697
11,185
13,203
16,091
18,260
19,118
19,914
20,563
16,882
18,330
19,893
17,911
22,284
29,453
30,816
Operating margin
15.8%
15.8%
14.7%
13.8%
16.4%
16.3%
17.3%
17.1%
17.2%
16.9%
16.3%
16.5%
17.1%
18.3%
19.0%
25.3%
25.3%
Depreciation (m)
217
268
339
342
397
635
840
895
939
1,051
1,128
1,238
1,308
1,190
1,775
2,168
2,258
Net profit (m)
1,122
1,370
1,318
1,152
1,793
2,172
2,392
2,695
2,598
3,357
2,554
2,492
2,651
3,008
3,646
6,433
6,329
Income tax rate
22.4%
25.8%
24.7%
19.2%
23.5%
20.9%
23.6%
24.4%
25.4%
21.8%
17.5%
16.0%
19.5%
26.4%
18.9%
16.5%
16.8%
Net profit margin
11.7%
12.4%
10.4%
10.3%
13.6%
13.5%
13.1%
14.1%
13.0%
16.3%
15.1%
13.6%
13.3%
16.8%
16.4%
21.8%
20.4%
Working capital (m)
935
1,150
1,442
2,460
2,425
2,100
3,382
4,586
4,035
1,666
(209)
2,058
2,252
20,665
6,400
3,508
- -
Long-term debt (m)
2,423
3,396
2,553
2,889
2,784
5,207
5,288
3,437
3,402
12,025
9,674
10,327
9,689
21,517
21,978
23,057
- -
Equity (m)
6,645
9,086
9,809
11,630
13,711
16,905
19,017
22,385
23,378
23,690
23,003
26,358
28,214
30,271
39,766
45,167
- -
ROIC
10.8%
9.1%
9.6%
7.4%
10.0%
8.7%
8.7%
9.3%
8.5%
7.9%
6.9%
6.3%
6.5%
5.1%
5.6%
8.8%
- -
Return on capital
11.2%
10.3%
10.7%
7.9%
11.1%
9.5%
9.9%
10.7%
9.8%
8.8%
7.1%
6.7%
7.2%
6.4%
6.3%
9.5%
- -
Return on equity
16.9%
15.1%
13.4%
9.9%
13.1%
12.8%
12.6%
12.0%
11.1%
14.2%
11.1%
9.5%
9.4%
9.9%
9.2%
14.2%
- -
Plowback ratio
97.8%
97.5%
97.1%
96.4%
97.1%
97.2%
96.4%
98.1%
91.2%
89.5%
65.3%
84.8%
83.7%
75.0%
83.1%
88.5%
87.5%
Div.&Repurch./FCF
(5.2)%
(39.2)%
1.8%
(8.2)%
(6.8)%
(45.9)%
17.7%
(4.1)%
3.0%
3.3%
24.6%
10.8%
10.0%
(44.2)%
(23.4)%
9.3%
10.7%
Capital Structure
1 Oct · 2022 | undefined
All numbers in millions
Total liabilities
$ - -
Total assets
$ - -
Long-term debt
$ - -
Cash and equiv.
$ - -
Goodwill
$ - -
Retained earnings
$ - -
Common stock
716
Enterprise Value
$ - -
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
19,912
6,035
2,586
Receivables
3,191
4,045
4,631
Inventory
1,628
2,292
2,767
Other
865
(12,447)
(15,662)
Current assets
25,597
13,802
11,648
Acc. Payable
1,514
2,049
2,569
Debt due
370
200
215
Other
3,048
5,153
5,356
Current liabilities
4,932
7,402
8,140
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
32.17%
13.79%
6.44%
Cash flow
30.40%
27.51%
11.90%
Earnings
76.44%
29.37%
14.38%
Dividends
20.65%
22.59%
59.55%
Book value
13.58%
14.82%
10.49%
Insider Trading
Type
Shares
Date
Rales Steven M
Other
28,280
09/19/22
Bouda Christopher
Award
9
09/09/22
Bouda Christopher
Award
10
08/26/22
Blair Rainer
Exempt
5,655
08/15/22
Blair Rainer
Exempt
19,345
08/15/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
4,343
5,297
5,883
6,760
22,284
2021
6,858
7,218
7,229
8,148
29,453
2022
7,688
7,751
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.84
1.31
1.25
1.76
5.16
2021
2.38
2.50
1.62
2.50
9.00
2022
2.41
2.32
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.20
0.21
0.23
0.24
0.87
2021
0.24
0.27
0.27
0.27
1.04
2022
0.27
0.31
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Diagnostics & Research
CEO:
Mr. Thomas Joyce
Full-time employees:
78,000
City:
WASHINGTON
Address:
2200 Pennsylvania Ave NW Ste 800w
IPO:
Dec 10, 1969
Website:
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.